Use of the TRH Stimulation Test to Assess Long Term Changes of Thyroid Function in an Olympic Athlete.

Abstract

This case report presents the utility of the thyroid-releasing hormone (TRH) stimulation test for assessing endocrine disease in athletes. On two occasions, 4 years apart (1992 and 1996), a TRH stimulation test was performed to corroborate clinical symptoms and observation. On the first occasion, the patient's symptoms were not attributed to thyroid disease. He was treated for a sinus infection with amoxicillin/clavulanate 500 mg three times per day for 1 wk. On the second occasion, thyroid disease was confirmed and treatment with 100-μg L-thyroxine was initiated. Baseline screening and TRH stimulation testing were used at both assessment time points. Baseline screen for TSH was 2.2 and 1.2 uUI·mL and stimulated TSH was at 15.2 uUI·mL at 30 min and 30.6 uUI·mL at 45 min for the first (1992) and second (1996) assessment, respectively. Patient was positive on the second visit for antithyroglobulin antibodies at 70 IU·mL (normal, 0-59 IU·mL). Three months postdiagnosis, TSH was 0.66 uIU·mL and the patient was asymptomatic. At the most recent visit, 20 years and 4 months later, no symptomology was reported and TSH was 0.55 uIU·mL A greater understanding of the interaction between stress and end organ function is warranted in occupations undergoing unique stressors.

• Authors: Jeffrey S Brown, Krista G Austin, Melissa Givens, F Carl Lewis
• Journal: Current sports medicine reports (Curr Sports Med Rep) Vol. 17 Issue 12 Pg. 454-456 (Dec 2018) ISSN: 1537-8918 [Electronic] United States
• PMID: 30531463 (Publication Type: Case Reports, Journal Article)

Chemical References

• Autoantibodies
• anti-thyroglobulin
• Thyrotropin-Releasing Hormone

Topics

• Adult
• Athletes
• Autoantibodies (blood)
• Humans
• Male
• Thyroid Diseases (diagnosis, therapy)
• Thyroid Gland (physiology, physiopathology)
• Thyrotropin-Releasing Hormone (analysis)